These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 25543221)
1. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia. Pousada G; Baloira A; Valverde D Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221 [TBL] [Abstract][Full Text] [Related]
2. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients. Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S; Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report. Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468 [TBL] [Abstract][Full Text] [Related]
4. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations. Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME; Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705 [TBL] [Abstract][Full Text] [Related]
5. [Hereditary pulmonary hypertension family with Lin YK; Yang DH; Lei C; Luo H Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun; 46(6):558-564. PubMed ID: 37278169 [No Abstract] [Full Text] [Related]
6. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970 [TBL] [Abstract][Full Text] [Related]
7. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia. Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816 [TBL] [Abstract][Full Text] [Related]
9. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype. Bossler AD; Richards J; George C; Godmilow L; Ganguly A Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392 [TBL] [Abstract][Full Text] [Related]
10. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients. Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382 [TBL] [Abstract][Full Text] [Related]
11. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia. Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373 [TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension. Chen YJ; Yang QH; Liu D; Liu QQ; Eyries M; Wen L; Wu WH; Jiang X; Yuan P; Zhang R; Soubrier F; Jing ZC Eur J Clin Invest; 2013 Oct; 43(10):1016-24. PubMed ID: 23919827 [TBL] [Abstract][Full Text] [Related]
14. The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure. Ayala E; Kudelko KT; Haddad F; Zamanian RT; de Jesus Perez V Chest; 2012 Jun; 141(6):1598-1600. PubMed ID: 22670022 [TBL] [Abstract][Full Text] [Related]
15. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations. Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389 [TBL] [Abstract][Full Text] [Related]
16. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1. Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827 [TBL] [Abstract][Full Text] [Related]
17. [Pulmonary arterial hypertension associated with human immunodeficiency virus infection: study of 4 cases]. Pousada G; Baloira A; Castro-Añón O; Valverde D Med Clin (Barc); 2016 Apr; 146(8):350-3. PubMed ID: 26897508 [TBL] [Abstract][Full Text] [Related]